‌

US Patent 11492662 Methods for in situ transcriptomics and proteomics

Patent 11492662 was granted and assigned to Singular genomics Systems, Inc. on November, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Singular genomics Systems, Inc.

0

Current Assignee

Singular genomics Systems, Inc.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Eli N. Glezer0

Hu Cang0

Zhenmin Hong0

Date of Patent

November 8, 2022

0

Patent Application Number

173965750

Date Filed

August 6, 2021

0

Patent Citations

US Patent 10774374 Spatially distinguished, multiplex nucleic acid analysis of biological specimens

0

US Patent 10495554 Method and system for imaging and analysis of a biological specimen

0

US Patent 10059990 In situ nucleic acid sequencing of expanded biological samples

0

US Patent 10114015 Assay methods

0

US Patent 10138509 Method for generating a three-dimensional nucleic acid containing matrix

US Patent 10266888 Method and apparatus for volumetric imaging of a three-dimensional nucleic acid containing matrix

0

US Patent 10323272 Nucleic acid probes for in situ hybridization

Patent Citations Received

US Patent 12006534 Spatial sequencing

0

US Patent 11891656 Methods for in situ transcriptomics and proteomics

0

US Patent 11915444 Single-pass primary analysis

0

Patent Primary Examiner

Ethan C. Whisenant

0

CPC Code

0

0

0

Disclosed herein, inter alia, are compositions and methods of use thereof for interrogating a cell.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11492662 Methods for in situ transcriptomics and proteomics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.